Left ventricular strain analysis using cardiac magnetic resonance imaging in patients undergoing in-centre nocturnal haemodialysis.


Journal

Nephrology (Carlton, Vic.)
ISSN: 1440-1797
Titre abrégé: Nephrology (Carlton)
Pays: Australia
ID NLM: 9615568

Informations de publication

Date de publication:
May 2019
Historique:
accepted: 16 05 2018
pubmed: 23 5 2018
medline: 4 9 2019
entrez: 23 5 2018
Statut: ppublish

Résumé

Intensified haemodialysis is associated with regression of left ventricular (LV) mass. Compared to LV ejection fraction, LV strain allows more direct assessment of LV function. We sought to assess the impact of in-centre nocturnal haemodialysis (INHD) on global LV strain (radial, circumferential, and longitudinal) and torsion by cardiac MRI (CMR). In this prospective, two-centre cohort study, 37 participants on conventional haemodialysis (CHD, 3-4 h/session for three sessions/week) converted to INHD (7-8 h/session for three sessions/week) and 30 participants continued CHD. Participants underwent CMR using a standardized protocol and had biomarker measurements at baseline and 52 weeks. Among the 55 participants (mean age 55; 40% women) with complete CMR data, those who converted to INHD had a significant improvement in their global circumferential strain (GCS, P = 0.025), while those continuing CHD did not have any significant changes in LV strain. When the two groups were compared, there was significant improvement in torsion. LV strains were significantly correlated with each other, but not with troponin I, C-reactive protein, or brain natriuretic protein (NT-proBNP), except for global longitudinal strain (GLS) with troponin I (P = 0.001) and NT-proBNP (P = 0.038). Conversion to INHD was associated with significant improvement in GCS over one year of study, although comparisons with the CHD group were not significant. There was also a significant decrease in torsion in the INHD group compared with CHD. Improvement in LV regional function would support the notion that INHD has favourable effects on both LV structure and function.

Identifiants

pubmed: 29785733
doi: 10.1111/nep.13404
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

557-563

Subventions

Organisme : Heart & Stroke Foundation
ID : G-14-0005856
Organisme : Canadian Institutes of Health Research
ID : MOP-89982
Pays : Canada

Informations de copyright

© 2018 Asian Pacific Society of Nephrology.

Auteurs

Jann P Ong (JP)

Division of Cardiology, St. Michael's Hospital, Toronto, Ontario, Canada.
University of Toronto, Toronto, Ontario, Canada.

Ron Wald (R)

University of Toronto, Toronto, Ontario, Canada.
Division of Nephrology, St Michael's Hospital, and Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada.

Marc B Goldstein (MB)

University of Toronto, Toronto, Ontario, Canada.
Division of Nephrology, St Michael's Hospital, and Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada.

Jonathon Leipsic (J)

Department of Radiology and Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.

Mercedeh Kiaii (M)

Division of Nephrology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.

Djeven P Deva (DP)

University of Toronto, Toronto, Ontario, Canada.
Department of Medical Imaging, St. Michael's Hospital, Keenan Research Centre of the Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada.

Anish Kirpalani (A)

University of Toronto, Toronto, Ontario, Canada.
Department of Medical Imaging, St. Michael's Hospital, Keenan Research Centre of the Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada.

Laura Jimenez-Juan (L)

University of Toronto, Toronto, Ontario, Canada.
Department of Medical Imaging, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Olugbenga Bello (O)

Division of Cardiology, St. Michael's Hospital, Toronto, Ontario, Canada.

Paymon M Azizi (PM)

University of Toronto, Toronto, Ontario, Canada.

Rachel M Wald (RM)

University of Toronto, Toronto, Ontario, Canada.
Division of Cardiology, Toronto General Hospital, Toronto, Ontario, Canada.

Graham A Wright (GA)

University of Toronto, Toronto, Ontario, Canada.
Schulich Heart Program and the Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Ziv Harel (Z)

University of Toronto, Toronto, Ontario, Canada.
Division of Nephrology, St Michael's Hospital, and Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada.

Kim A Connelly (KA)

Division of Cardiology, St. Michael's Hospital, Toronto, Ontario, Canada.
University of Toronto, Toronto, Ontario, Canada.

Andrew T Yan (AT)

Division of Cardiology, St. Michael's Hospital, Toronto, Ontario, Canada.
University of Toronto, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH